Alexander Nolte - Feb 2, 2023 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Chief Accounting Officer
Signature
/s/ Michael A. Metzger, Attorney-in-fact
Stock symbol
SNDX
Transactions as of
Feb 2, 2023
Transactions value $
$485,350
Form type
4
Date filed
2/3/2023, 03:58 PM
Previous filing
Feb 3, 2022
Next filing
May 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNDX Stock Options (Right to buy) Award $485K +17K $28.55 17K Feb 2, 2023 Common Stock 17K $28.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option shall vest monthly over a four-year period.